RxDoctor Payments Data

Funmilayo Fashola

Psychiatric/Mental Health · Washington, DCNPI 1952067878

Payments from drug & device makers

$72in general payments, 2019–2025

Across 3 payments — averaging $23.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$30
  • Lundbeck LLC$27
  • Otsuka America Pharmaceutical, Inc.$15

What the payments were for

  • Food & beverage$72100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$72 in reported general payments places this provider in the 25th percentile of 137 psychiatric/mental health providers in District of Columbia.

See all psychiatric/mental health providers in District of Columbia

Medicare billing

Part B allowed, 2024
$361,139
Medicare patients
130
Services billed
2,694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole17$408
Sertraline Hcl21$323
Trazodone Hcl16$192

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →